Predict your next investment

Corporation
HEALTHCARE | Biotechnology
beckmancoulter.com

See what CB Insights has to offer

Founded Year

1935

Stage

Grant | Alive

About Beckman Coulter

Beckman Coulter develops, manufactures, and markets products that simplify, automate, and innovate complex biomedical testing. The company's diagnostic systems are found in hospitals and other critical care settings around the world, producing information used by physicians to diagnose disease, making treatment decisions, and monitoring patients. Scientists use the company's life science research instruments to study complex, biological problems, including causes of disease and potential new therapies or drugs.Beckman Coulter operates as a subsidiary of Danaher.

Beckman Coulter Headquarter Location

250 South Kraemer Boulevard

Brea, California, 92821,

United States

+1 714 993 5321

Latest Beckman Coulter News

07:30 ET Lateral Flow Assay Market to Ascend at 5.1% CAGR as Demand for Rapid Point-of-Care Testing Upsurges

Nov 30, 2021

News provided by Share this article Share this article NEW YORK, Nov. 30, 2021 /PRNewswire/ -- As per Persistence Market Research's latest industry analysis, the global lateral flow assay market  is expected to witness high growth during the forecast period, from US$ 3.7 Bn in 2020 to over US$ 6.4 Bn by 2031. This reflects a CAGR of around 5.1% over the forecast period (2021-2031). Persistence_Market_Research Lateral flow assays are mainly used for diagnostics for home testing, laboratory use, and point-of-care testing. The most widely applied and well-known applications of lateral flow assays are home pregnancy tests. Demand for lateral flow assays is increasing due to growing adoption of home-based lateral flow assay kits, demand growth of point-of-care testing, and rise in adoption of LFA kits due to their advantages over laboratory tests. Rising prevalence of infectious diseases is a prime driver for the market. Emergence of diseases such as coronavirus, Zika virus, Ebola, and others has increased the procurement of point-of-care testing devices and kits by international bodies such as UNICEF. Furthermore, the current COVID-19 pandemic has boosted demand for lateral flow tests. COVID-19 infections are diagnosed with lateral flow assay-based tests across the world Mobile phones provide rapid results in real time, saving time and reducing result reporting delays. They also allow users to record the time and results of a test. Further, easy and cost-effective sharing of data along with cloud integration has resulted in better centralization and analysis of data using online information sharing platforms. This technology enables clinicians or patients in remote areas to image samples that can be used for TB and malaria diagnosis. In January 2021, Sensyne Health, based in the United Kingdom, released MagnifEye, a revolutionary smartphone software that uses deep machine learning and AI to automate the accurate interpretation of lateral flow diagnostic tests. Request for sample PDF of report: https://www.persistencemarketresearch.com/samples/11236 Key Takeaways from Market Study By product, LFA kits will hold a high share of 70% in 2021, expanding at a mid-single digit CAGR during the forecast period. Primary factors that support rising adoption of products in this segment include ease of use, low cost, and ease of production. By indication, infectious disease is expected to hold well over 50% market share in 2021, and is expected to continue growing at a moderate rate in correlation with increasing prevalence of infectious diseases globally. High adoption of point-of-care testing for quick diagnosis at hospitals has led to the hospital pharmacies hold a high market share. By region, North America held nearly 1/3 of the global market share in 2021. This is attributed to rise in health care expenditures, increasing adoption of lateral flow assays, and presence of prominent players in the region. Get Customized report as per requirement: https://www.persistencemarketresearch.com/request-customization/11236   "Although the COVID-19 pandemic boosted market growth in 2020, it is expected to be a temporary phase. However, developments such as smartphone-based readers for LFA will continue to provide fruitful growth opportunities for market players over the coming years," says an analyst of Persistence Market Research. Market Competition Some of the leading manufacturers of lateral flow assays are focusing on product approvals and launches as the key growth strategy for global expansion, thereby enhancing their market presence. In June 2021, Bio-Rad Laboratories announced the release of its PREvalence ddPCR SARS-CoV-2 wastewater quantifying kit, which is an accurate, sensitive, and cost-effective technique for detecting SARS-CoV-2 infection in community wastewater. The test aids a community in determining if the virus has been prevalent for days or weeks before it is discovered among people. In August 2020, Abbott announced that the US FDA granted an Emergency Use Authorization (EUA) for its BinaxNOWTM COVID-19 Ag Card fast test for COVID-19 infection detection. In August 2017, Beckman Coulter received FDA clearance for the first IVD test delivering flow cytometric leukaemia & lymphoma analysis in routine clinical labs. Key market players covered by Persistence Market Research include Abbott Laboratories, bioMerieux S.A, Bio-Rad Laboratories Inc., Danaher Corporation, QIAGEN N.V., Thermo Fisher Scientific, Inc., Siemens Healthineers, Hologic Inc., and F. Hoffmann-La Roche Ltd. Get full access of report: https://www.persistencemarketresearch.com/checkout/11236 What Does the Report Cover? Persistence Market Research offers a unique perspective and actionable insights on the lateral flow assay market in its latest study, presenting historical demand assessment of 2016 – 2020 and projections for 2021 – 2031. The research study is based on the product (readers {bench-top readers and hand-held readers}, LFA kits {test strips, dipsticks, cassettes, and lancets}), indication (infectious diseases {mosquito-borne diseases, streptococcus infections, sexually transmitted diseases, hepatitis, tuberculosis, gastrointestinal infections, and others}, pregnancy test, and drug of abuse testing), and distribution channel (hospital pharmacies, retail pharmacies, supermarkets/hypermarkets, and e-Commerce), across five major regions of the world. Related Reports: About Persistence Market Research: Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches. Overview: Persistence Market Research is always way ahead of its time. In other words, it tables market solutions by stepping into the companies'/clients' shoes much before they themselves have a sneak pick into the market. The pro-active approach followed by experts at Persistence Market Research helps companies/clients lay their hands on techno-commercial insights beforehand, so that the subsequent course of action could be simplified on their part. Contact

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Beckman Coulter

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Beckman Coulter is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

3,805 items

Companies that received PMA from the FDA since 2014. Companies tagged as #FDAPMA

H

Health Monitoring & Diagnostics

701 items

Companies developing technology to facilitate near-patient and point-of-care (POC) in vitro diagnostic testing. Companies tagged as #NearPatient&POCTesting

Beckman Coulter Patents

Beckman Coulter has filed 395 patents.

The 3 most popular patent topics include:

  • Laboratory equipment
  • Blood tests
  • Cell biology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/13/2018

11/9/2021

Fluid dynamics, Rotation, Interbasin transfer, Closed amusement attractions, Dark rides

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

3/13/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

11/9/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Fluid dynamics, Rotation, Interbasin transfer, Closed amusement attractions, Dark rides

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Beckman Coulter Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Beckman Coulter Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.